Overview
- Starting this fall, Ontarians aged 75 and up will be eligible for a publicly funded RSV shot ahead of respiratory virus season.
- Until now, provincial funding covered only high‑risk seniors 60 to 74, alongside infants in their first RSV season and certain high‑risk young children.
- Pregnant women will continue to have publicly covered access to an RSV vaccine to help protect newborns.
- Canada’s immunization advisory committee strongly recommends RSV vaccination for those 75 and older, and Health Canada has authorized three adult vaccines, including an mRNA option.
- Infant protection has expanded through the seasonal monoclonal antibody nirsevimab, with early Quebec preprint data reporting reductions of over 85% in key infant hospital outcomes where universal infant coverage was used.